Table 4. Multivariate prognostic factors for overall mortality among the 360 patients with non-metastatic resected gastric cancer.
Variate | HR | 95% Cl | P |
Age at diagnosis | |||
65–70 years | 1.00 | Referent | - |
>70 years | 1.22 | 0.91–1.62 | 0.19 |
Gender | |||
Male | 1.00 | Referent | - |
Female | 0.87 | 0.62–1.22 | 0.421 |
Chalson index | |||
0 | 1.00 | Referent | - |
1 | 1.12 | 0.79–1.58 | 0.521 |
2+ | 0.68 | 0.28–1.69 | 0.409 |
Time of diagnosis | |||
1999–2003 | 1.00 | Referent | - |
2004–2007 | 0.98 | 0.72–1.33 | 0.886 |
Location of tumor | |||
Proximal | 1.00 | Referent | - |
Distal | 0.55 | 0.39–0.77 | 0.001* |
Size | |||
≤5 cm | 1.00 | Referent | - |
>5 cm | 1.54 | 1.14–2.07 | 0.004* |
Grade | |||
Well or moderately differentiated | 1.00 | Referent | - |
Poorly differentiated or undifferentiated | 1.64 | 1.18–2.30 | 0.004* |
T category | |||
T1/T2 | 1.00 | Referent | - |
T3 | 1.65 | 0.75–3.65 | 0.217 |
T4 | 2.90 | 1.54–5.45 | 0.001* |
N category | |||
N0 | 1.00 | Referent | - |
N1 | 2.03 | 1.34–3.07 | 0.001* |
N2 | 2.22 | 1.46–3.37 | <0.001* |
N3 | 3.49 | 2.25–5.39 | <0.001* |
Treatment | |||
Surgery alone | 1.00 | Referent | - |
Adjuvant chemotherapy | 0.60 | 0.42–0.83 | 0.003* |
Abbreviations: CI, confidence interval; T, tumor; N, lymph node.
Statistically significant.